TGFB2 and neoplasm: In particular, it has been hypothesized that TGFβ2 may have different effects on tumor growth at different stages of the disease, acting as an inhibitor at the early stages and as activator at the late stages [55,56]; moreover, it has recently been shown to antagonize IL-6-induced survival and promote cell apoptosis [57].